Drugs and Health News

Tris Pharma, Inc. Announced First Ever FDA-Approved Extended-Release Chewable Tablet

FDA Approved Expanded Age Indication For GARDASIL 9 In Males For HPV

BRIDION (Sugammadex) Received FDA Approval For The Reversal Of Neuromuscular Blockade Induced By Rocuronium And Vecuronium In Adults Undergoing Surgery

FDA Greenlights AstraZeneca PLC’s Gout Drug Zurampic

Eagle Pharma And Teikoku Pharma Won FDA Approval of Docetaxel Injection, First and Only Alcohol-Free Formulation

Seaweed Capsules May Lead To An Injection-Free Life For Diabetic Patients

Genmab A/S Announced FDA Approval Of DARZALEX (Daratumumab) For Multiple Myeloma

Alcresta Received FDA Clearance For RELiZORB

High-Fat Diets May Cause Brain Damage

Common Antidepressant Meds Could Protect Against Dementia

Slow Walking Could Be An Early Sign Of Alzheimer’s

FDA Grants Orphan Drug Designation To TapImmune Inc. TPIV 200 In The Treatment Of Ovarian Cancer

Teligent Inc., Announced FDA Approval Of CEFOTAN (cefotetan) For Injection